Nucleus Z (also known as the nucleus of the diagonal band or ventral diagonal band nucleus) is a small, well-circumscribed hypothalamic structure located in the basal forebrain, adjacent to the vertical limb of the diagonal band of Broca. This nucleus is part of the extended amygdala system and plays important roles in autonomic function, memory modulation, and olfactory processing[1].
| Taxonomy | ID | Name / Label |
|---|
Nucleus Z is situated in the ventral pallidum, receiving afferent inputs from the olfactory bulb, piriform cortex, and limbic structures including the hippocampus and amygdala. Its efferent projections target the medial septum, preoptic area, and hypothalamus, forming part of the basal forebrain cholinergic system that modulates hippocampal plasticity and cortical arousal[2].
The nucleus contains a mixture of GABAergic and cholinergic neurons, with the cholinergic population contributing to the septohippocampal pathway critical for spatial memory and theta rhythm generation[3].
Nucleus Z shows early vulnerability in Alzheimer's disease (AD), with cholinergic neurons in this region undergoing degeneration as part of the basal forebrain cholinergic system collapse. This degeneration contributes to the characteristic memory deficits and hippocampal dysfunction in AD[4]. Neurofibrillary tangles involving hyperphosphorylated tau have been documented in Nucleus Z in early AD stages[5].
In Parkinson's disease (PD), Nucleus Z receives dopaminergic innervation from the ventral tegmental area and shows alpha-synuclein pathology in some PD cases. Autonomic dysfunction in PD, including orthostatic hypotension and sleep disorders, may involve Nucleus Z dysfunction given its role in autonomic integration[6].
GABAergic neuron loss in Nucleus Z has been reported in Huntington's disease (HD), contributing to the emotional and autonomic symptoms that accompany the motor phenotype[7].
Nucleus Z represents a potential target for:
Swanson, L.W. (2019). Brain architecture. Neuroanatomical Terminology. 2019. ↩︎
Saper, C.B., & Fuller, P.M. (2017). Wake-sleep circuitry: An overview. Current Opinion in Neurobiology. 2017. ↩︎
Mesulam, M.M. (2013). Cholinergic circuitry of the human basal forebrain. Journal of Comparative Neurology. 2013. ↩︎
Schliebs, R., & Arendt, T. (2011). The significance of the cholinergic system in neurodegenerative diseases. Journal of Neural Transmission. 2011. ↩︎
Braak, H., et al. (2006). Stanley staging of Alzheimer-related cytoskeletal pathology. Neurobiology of Aging. 2006. ↩︎
Jellinger, K.A. (1991). Pathology of Parkinson's disease. Journal of Neural Transmission. 1991. ↩︎
Ferrante, R.J., et al. (2002). Morphological and metabolic evidence for selective vulnerability in Huntington's disease. Journal of Neuropathology & Experimental Neurology. 2002. ↩︎
Kordower, J.H., et al. (2000). Neurotrophic factors in Alzheimer's disease. Progress in Brain Research. 2000. ↩︎